Bovine Respiratory Disease (BRD): Mannheimia haemolytica Pathogenesis and Diagnostics in Cattle

Introduction

Bovine respiratory disease (BRD) remains the most economically significant infectious disease affecting cattle production systems worldwide. BRD is a multifactorial syndrome involving interactions among host immunity, environmental stressors, and a consortium of viral and bacterial pathogens [1, 3]. Among the bacterial agents, Mannheimia haemolytica (formerly Pasteurella haemolytica biotype A serotype 1) is the most frequently isolated bacterium from acute fibrinous pneumonia in feedlot cattle and is considered the primary causative agent of the clinical entity known as shipping fever [4, 5]. Understanding the specific pathogenic mechanisms of M. haemolytica and the diagnostic modalities available for its detection is critical for effective disease management and antimicrobial stewardship.

This article provides an exhaustive review of M. haemolytica pathogenesis, the clinical presentation of shipping fever, and the spectrum of diagnostic tools ranging from traditional clinical examination to modern molecular and computational approaches. Emphasis is placed on the biophysical and molecular interactions between the pathogen and the bovine respiratory tract.

Pathogenesis of Mannheimia haemolytica

M. haemolytica is a Gram-negative coccobacillus belonging to the family Pasteurellaceae. It colonizes the upper respiratory tract (nasopharynx and tonsils) of healthy cattle as a commensal. Disease develops when host defense mechanisms are compromised by viral infections (e.g., bovine respiratory syncytial virus (BRSV), bovine herpesvirus 1, bovine viral diarrhea virus (BVDV), and Bovine Coronavirus) or environmental stressors such as transportation, weaning, overcrowding, and poor ventilation [3, 20]. Stress-induced immunosuppression allows M. haemolytica to proliferate and invade the lower respiratory tract, where it triggers an intense inflammatory response.

Adhesion and Colonization

The initial step in pathogenesis involves adherence of M. haemolytica to alveolar epithelium and pulmonary endothelium. The bacterium expresses several adhesins, including filamentous hemagglutinin-like proteins and autotransporter adhesins, which bind to host extracellular matrix components and cell surface receptors [7, 11]. Fimbriae and lipopolysaccharide (LPS) also contribute to attachment and immune activation.

Leukotoxin: The Central Virulence Factor

The hallmark virulence factor of M. haemolytica is a secreted, repeats-in-toxin (RTX) exotoxin called leukotoxin (LktA). LktA is a calcium-dependent pore-forming toxin that specifically targets ruminant leukocytes, including neutrophils, macrophages, and lymphocytes, by binding to the CD18 subunit of β2 integrins [3, 7]. The toxin induces a dose-dependent effect: at low concentrations, it triggers apoptosis and inflammatory mediator release from alveolar macrophages; at high concentrations, it causes cytolysis and degranulation of neutrophils.

The release of neutrophil contents, including proteases, reactive oxygen species, and matrix metalloproteinases, results in severe tissue damage characteristic of acute fibrinous bronchopneumonia. Fibrin accumulation, thrombosis, and necrotic foci are hallmarks of M. haemolytica pneumonia [1, 10]. The exotoxin also impairs mucociliary clearance and disrupts the alveolar-capillary barrier, leading to edema and consolidation.

Other Virulence Factors

Lipopolysaccharide (LPS) from M. haemolytica activates toll-like receptor 4 (TLR4) signaling, promoting a massive influx of neutrophils and secretion of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and IL-8 [7, 15]. Capsular polysaccharide, outer membrane proteins (e.g., OmpA, OmpP2), and iron acquisition systems further enhance survival within the host. M. haemolytica also produces a neuraminidase that degrades sialic acid residues on host glycoproteins, potentially enhancing adherence.

Coinfections and Disease Exacerbation

BRD pathogenesis is rarely monomicrobial. Primary viral infections impair mucociliary clearance, disrupt epithelial integrity, and suppress phagocyte function, creating a permissive environment for M. haemolytica superinfection [3, 5]. Cluster analysis of BRD outbreaks identified two epidemiological patterns: one where viruses are commonly detected with Pasteurella multocida and M. haemolytica (cluster 1, affecting younger calves in cold months), and another where viruses are less frequent but Histophilus somni and Mycoplasma bovis are more prominent (cluster 2, older calves at feedlot arrival) [5, 18]. Mixed infections involving M. haemolytica with BVDV, BRSV, or Mycoplasma bovis increase lesion severity and mortality risk [10].

Clinical Presentation: Shipping Fever

Shipping fever is the classic clinical manifestation of acute M. haemolytica pneumonia. The term arose from the strong association with transport stress. Incubation is typically 2-5 days after stress exposure. Clinical signs develop rapidly and include:

• Fever: rectal temperature often exceeds 40.0 °C (104 °F) [21].
• Depression: lethargy, drooping ears, reluctant to move.
• Anorexia: reduced feed intake, which can be detected days before overt signs using automated feeders [12, 13].
• Respiratory signs: tachypnea, dyspnea, nasal discharge (serous to mucopurulent), coughing, and open-mouth breathing in severe cases.
• Ocular discharge: serous to purulent [21].
• Posture: arched back, head extended (orthopnea).

Thoracic auscultation may reveal increased bronchial tones, crackles, or wheezes, but has low sensitivity for detecting consolidation in pre-weaned calves [2]. Ultrasonography is more accurate for identifying lung consolidation and pleural effusion [1, 2]. Chronic cases may present with reduced weight gain, poor carcass quality, and pleural lesions at slaughter [22].

Diagnostic Methods

Accurate diagnosis of BRD and specific identification of M. haemolytica are essential for targeted therapy and antimicrobial stewardship. A multimodal approach combining clinical, imaging, microbiological, and molecular techniques is currently recommended [1, 25].

Clinical Scoring Systems

The Wisconsin Calf Respiratory Scoring Chart (University of Wisconsin) is widely used for pre-weaned dairy calves. It assigns points based on rectal temperature, cough, nasal discharge, ocular discharge, and ear/head position. A cumulative score ≥ 5 indicates BRD [2, 13]. However, specificity is limited, and training is required to achieve consistent inter-observer agreement [21].

The DART (Depression, Appetite, Respiration, Temperature) system and the Apleval system are used in feedlots. These systems rely on visual observation and have moderate sensitivity (62-84%) and specificity (74-89%) [25].

Thoracic Ultrasonography

Thoracic ultrasound (TUS) is a point-of-care imaging modality that can detect lung consolidation (≥1 cm depth) and pleural irregularities. TUS has higher sensitivity than auscultation for identifying pneumonia in calves [2, 24]. A scanning protocol using a linear or convex probe on the right and left thorax (intercostal spaces 7-11) is standard. Consolidation appears as anechoic or hypoechoic regions with hyperechoic air bronchograms. TUS scores correlate with severity of lesions found at slaughter [22].

Pathogen Detection: Culture and Phenotypic Methods

Traditional culture of deep nasopharyngeal swabs, bronchoalveolar lavage (BAL) fluid, or lung tissue at necropsy remains the gold standard for isolating M. haemolytica. Samples are plated on blood agar and MacConkey agar. M. haemolytica forms gray, mucoid colonies; Gram staining shows pleomorphic Gram-negative rods. Biochemical differentiation from P. multocida and H. somni is based on oxidase and catalase reactions, indole production, and sugar fermentation patterns [23].

Culture also enables antimicrobial susceptibility testing (AST) via disk diffusion or broth microdilution [14, 27]. However, culture is time-consuming (24-48 h) and sensitivity is decreased in animals that have received antimicrobials recently.

Molecular Diagnostics: PCR and qPCR

Real-time polymerase chain reaction (PCR) and quantitative PCR (qPCR) are now standard for rapid and specific detection of M. haemolytica nucleic acids directly from respiratory specimens. Several commercial and in-house multiplex assays target the lktA gene (leukotoxin) for species-specific detection, along with genes for P. multocida, H. somni, M. bovis, and common viral pathogens [9, 17, 18].

A one-step multiplex RT-qPCR can simultaneously detect BVDV, BoHV-1, BPIV3, BRSV, and influenza D virus [17]. Another multiplex assay targets M. haemolytica, P. multocida, H. somni, M. bovis, and seven pathogens in a single reaction [18]. These assays have detection limits as low as 10-100 copies per reaction and turnaround times under 3 hours.

Quantitative PCR is particularly valuable for distinguishing high-level shedding of M. haemolytica (associated with disease) from low-level carriage (normal flora). Studies show that higher numbers of M. haemolytica and H. somni in BAL fluid are significantly associated with clinical BRD [23].

Metagenomics and Long-Read Sequencing

Shotgun metagenomics and long-read sequencing (e.g., using long-read sequencing technologies) provide unbiased profiling of the entire respiratory microbiome, including bacteria, viruses, and antimicrobial resistance genes (ARGs) [6, 27]. Metagenomic analysis of nasal swabs from BRD-affected cattle revealed a dysbiosis characterized by increased abundance of M. haemolytica, Trueperella pyogenes, and Mycoplasma spp., and decreased alpha diversity [11]. Integration of metagenomics with machine learning classifiers can distinguish BRD from healthy animals with misclassification rates around 32% [11].

Resistome profiling using metagenomics has identified integrative and conjugative elements (ICEs) carrying multidrug resistance genes in M. haemolytica strains from feedlot cattle [14]. These elements are transferable among Pasteurellaceae and may spread resistance under antimicrobial selection pressure.

Serology

Antibody detection (ELISA and virus neutralization) is primarily used for surveillance of viral exposure in herds rather than for individual diagnosis of M. haemolytica infection [9, 16]. However, rising antibody titers to M. haemolytica leukotoxin (anti-LktA) can be used in research to confirm recent exposure.

Biomarkers and Acute Phase Proteins

Serum haptoglobin, serum amyloid A, and fibrinogen levels increase during BRD and may aid in case identification. Fibrinogen concentration above a threshold > 7 g/L shows moderate sensitivity and specificity [1]. More recent studies explore inflammatory cytokines (IL-6, TNF-α) and point-of-care lactate measurements, but none have been validated as standalone diagnostics for M. haemolytica.

Machine Learning and Precision Technologies

Precision livestock farming technologies, including automated milk feeders, accelerometers, and pedometers, can capture behavioral deviations days before clinical signs appear. Feeding behavior (reduced intake, slower drinking speed) and activity (increased lying time, reduced steps) are strong predictors of impending BRD [8, 12, 13]. Machine learning models (e.g., K-nearest neighbor, random forest, cost-aware feature selection) trained on these data can predict BRD status with up to 94% accuracy and detect illness up to six days before conventional diagnosis [8, 13].

These technologies are particularly useful for M. haemolytica pneumonia because early intervention before severe lung damage improves outcomes and reduces antimicrobial use [19].

Diagnostic Workflow

The following diagram outlines a recommended diagnostic decision tree for BRD in cattle integrating clinical, molecular, and precision technology approaches:

flowchart TD
    A[Calves identified by farm staff or automated systems], > B{Risk assessment based on transport, age, season?}
    B, >|High risk| C[Implement active surveillance: automated feeders, accelerometers]
    B, >|Low risk| D[Standard visual health checks]

    C, > E[Behavioral alerts from algorithms]
    D, > F[Clinical scoring system<br>(e.g., Wisconsin score >=5)]

    E, > G[Confirm with physical exam + TUS]
    F, > G

    G, > H{Thoracic ultrasound<br>consolidation ≥1 cm?}
    H, >|No| I[Monitor; consider recheck in 48h]
    H, >|Yes| J[Collect deep nasal swab or BAL]

    J, > K[Multiplex qPCR for M. haemolytica,<br>P. multocida, H. somni, M. bovis, viruses]
    K, > L{Result: M. haemolytica positive<br>with high Ct value?}
    L, >|Yes| M[Initiate targeted antimicrobial therapy<br>based on local AST data]
    L, >|No, other pathogen or low load| N[Consider alternative etiologies<br>(viral, H. somni, M. bovis)]

    M, > O[Re-evaluate at 72h: clinical improvement?]
    O, >|Yes| P[Complete treatment course]
    O, >|No| Q[Perform culture and AST, adjust therapy]

    N, > R[Manage according to specific pathogen]
    L, >|Severe outbreak| S[Submit samples for metagenomic resistome profiling]

Antimicrobial Treatment and Resistance

Antimicrobial therapy for M. haemolytica pneumonia should be guided, when possible, by AST results. However, empirical treatment is often initiated based on class and regional resistance patterns. Commonly used antimicrobial classes include tetracyclines (oxytetracycline), florfenicol, tulathromycin (macrolide), ceftiofur (cephalosporin), and enrofloxacin (fluoroquinolone) [4, 14].

Multidrug resistance is a growing concern in M. haemolytica isolates from diseased cattle. Resistance genes such as tet(H), floR, erm(42), and AAC(6')-aph(2") are frequently carried on ICEs [14]. Macrolide resistance in M. haemolytica has been documented in North American feedlots [14, 27]. Use of antimicrobials in feed can accelerate horizontal transfer of resistance genes [28].

Veterinarians should implement antimicrobial stewardship principles: use narrow-spectrum agents when possible, adhere to label dose and duration, avoid prophylactic mass medication, and incorporate culture-based AST for treatment failures [29].

Prevention and Control

Control of M. haemolytica pneumonia relies on reducing stress and enhancing immunity through:

• Vaccination: Commercial vaccines include modified-live or killed bacterins and leukotoxin toxoids. Vaccines are often administered before weaning or at feedlot arrival. Efficacy varies; protection against heterologous strains may be incomplete [4, 15].
• Metaphylaxis: Group treatment with long-acting antimicrobials at arrival is used in some high-risk feedlots but contributes to resistance [14].
• Biosecurity: Minimizing commingling, improving ventilation, and reducing dust and ammonia levels lower pathogen transmission. A national control program for BRSV and bovine coronavirus in Norway demonstrates that biosecurity can reduce BRD incidence without vaccination [16].
• Nutritional support: Adequate colostrum intake, trace minerals (zinc, copper, selenium), and vitamins A and E support immune function.

Future Perspectives

Advances in diagnostic technology continue to refine BRD detection. The integration of point-of-care PCR (including point-of-care molecular diagnostics adapted for cattle) and microfluidic platforms promises rapid on-farm pathogen identification. Recombinase polymerase amplification (RPA) is a low-resource alternative to PCR that may be deployed for M. haemolytica detection [27].

Computational biology, including biological foundation models for predicting host-microbe interactions and machine learning algorithms for predicting outbreaks, can enhance early warning systems. Cloud-based integration of behavioral data and diagnostic results supports herd-level decision making.

Furthermore, the development of 3D in vitro models of the bovine airway (air-liquid interface cultures and organoids) will enable detailed study of M. haemolytica pathogenesis and testing of new therapeutic interventions without the need for live animals [7].

Conclusion

Mannheimia haemolytica remains the principal bacterial driver of acute fibrinonecrotic pneumonia in cattle with BRD. Its pathogenesis centers on leukotoxin-mediated neutrophil destruction and a dysregulated inflammatory cascade. Accurate diagnostic approaches now combine clinical assessment, thoracic ultrasound, multiplex molecular panels, and behavioral monitoring via precision technologies. These tools, used in concert, support early detection and targeted antimicrobial therapy, which are essential for reducing economic losses and slowing the emergence of antimicrobial resistance. Continued research into host-pathogen interactions and rapid point-of-care diagnostics will further improve BRD management at the individual and herd levels.

References

[1] Kamel, M., Davidson, J.L., Verma, M.S. "Strategies for Bovine Respiratory Disease (BRD) Diagnosis and Prognosis: A Comprehensive Overview." Animals, 2024. URL: https://www.semanticscholar.org/paper/e89787bed5475ee48727d8bb7bfa5cf8128ea713

[2] Berman, J. "Literature Review of the Principal Diagnostic Tests to Detect Bovine Respiratory Disease in Pre-Weaned Dairy and Veal Calves." Animals, 2024. URL: https://www.semanticscholar.org/paper/f79c4549c93f0f1238dcb8a5300545fbfba297a4

[3] Gaudino, M., Nagamine, B.S., Ducatez, M., et al. "Understanding the mechanisms of viral and bacterial coinfections in bovine respiratory disease: a comprehensive literature review of experimental evidence." Veterinary Research, 2022. URL: https://www.semanticscholar.org/paper/3b2c5d8b36bfc15f2416a69b80a5eb12fb37ed94

[4] Cusack, P. "Evaluation of practices used to reduce the incidence of bovine respiratory disease in Australian feedlots (to November 2021)." Australian Veterinary Journal, 2023. URL: https://www.semanticscholar.org/paper/c480bdbd96002e7fc94be30fb88ae4457b4ea406

[5] Calderón Bernal, J.M., Fernández, A., Arnal, J.L., et al. "Cluster analysis of bovine respiratory disease (BRD)-associated pathogens shows the existence of two epidemiological patterns in BRD outbreaks." Veterinary Microbiology, 2023. URL: https://www.semanticscholar.org/paper/70ce8cc7675021ec501cad2876088e22ae635b81

[6] Ambrose, R., Blakebrough-Hall, C., Gravel, J., et al. "Characterisation of the Upper Respiratory Tract Virome of Feedlot Cattle and Its Association with Bovine Respiratory Disease." Viruses, 2023. URL: https://www.semanticscholar.org/paper/d297fa1c84960b8d04a0a485bb07f2f51caf1c9d

[7] Gandhi, N., Inzana, T., Rajagopalan, P. "Bovine Airway Models: Approaches for Investigating Bovine Respiratory Disease." ACS Infectious Diseases, 2023. URL: https://www.semanticscholar.org/paper/230670f771e0b5709833aab8542e2f85a1c68106

[8] Casella, E., Cantor, M., Setser, M., et al. "A Machine Learning and Optimization Framework for the Early Diagnosis of Bovine Respiratory Disease." IEEE Access, 2023. URL: https://www.semanticscholar.org/paper/cbb3440a306e27004e3e9fec62b2c3d9c1e58037

[9] Goto, Y., Fukunari, K., Suzuki, T. "Multiplex RT-qPCR Application in Early Detection of Bovine Respiratory Disease in Healthy Calves." Viruses, 2023. URL: https://www.semanticscholar.org/paper/57f70791c107e9d7566dfea1be42a67807d737be

[10] Zhou, Y., Shao, Z., Dai, G., et al. "Pathogenic infection characteristics and risk factors for bovine respiratory disease complex based on the detection of lung pathogens in dead cattle in northeast China." Journal of Dairy Science, 2022. URL: https://www.semanticscholar.org/paper/5e008033448181e52cb71e2ce4a2962e9e964b79

[11] Centeno-Martinez, R.E., Glidden, N., Mohan, S., et al. "Identification of bovine respiratory disease through the nasal microbiome." Animal Microbiome, 2022. URL: https://www.semanticscholar.org/paper/2f14de7461e76a212f3e8302bb4d665442cd48dc

[12] Cantor, M., Costa, J. "Daily behavioral measures recorded by precision technology devices may indicate bovine respiratory disease status in preweaned dairy calves." Journal of Dairy Science, 2022. URL: https://www.semanticscholar.org/paper/ba237e517229631f750c1171f474cf039689b8b7

[13] Cantor, M., Casella, E., Silvestri, S., et al. "Using Machine Learning and Behavioral Patterns Observed by Automated Feeders and Accelerometers for the Early Indication of Clinical Bovine Respiratory Disease Status in Preweaned Dairy Calves." Frontiers in Animal Science, 2022. URL: https://www.semanticscholar.org/paper/c1d83b2572c916d0508d827ac427b3c608a70869

[14] Andrés-Lasheras, S., Jelinski, M., Zaheer, R., et al. "Bovine Respiratory Disease: Conventional to Culture-Independent Approaches to Studying Antimicrobial Resistance in North America." Antibiotics, 2022. URL: https://www.semanticscholar.org/paper/3a7ac99d0e804dde893e800e564bdef6088ec005

[15] Makoschey, B., Berge, A. "Review on bovine respiratory syncytial virus and bovine parainfluenza – usual suspects in bovine respiratory disease – a narrative review." BMC Veterinary Research, 2021. URL: https://www.semanticscholar.org/paper/42ea873884223e85bbfbbfb8a32318188551dae7

[16] Stokstad, M., Klem, T., Myrmel, M., et al. "Using Biosecurity Measures to Combat Respiratory Disease in Cattle: The Norwegian Control Program for Bovine Respiratory Syncytial Virus and Bovine Coronavirus." Frontiers in Veterinary Science, 2020. URL: https://www.semanticscholar.org/paper/1b689d1cea7756cd990f6c8322a9a75351408135

[17] Zhang, J., Wang, W., Yang, M., et al. "Development of a One-Step Multiplex Real-Time PCR Assay for the Detection of Viral Pathogens Associated With the Bovine Respiratory Disease Complex." Frontiers in Veterinary Science, 2022. URL: https://www.semanticscholar.org/paper/8540c6bb